A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany

BackgroundThis epidemiologic cohort study documented clinical and serological data in MS patients over several vaccination cycles against severe respiratory syndrome coronavirus-2 (SARS-CoV-2) in a real-world setting.MethodsAdult patients with MS were included during a period of 26 months from July...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Achim Berthele, Clemens Gödel, Boris-Alexander Kallmann, Markus Kowarik, Klaus Lehmann-Horn, Martin Marziniak, Sebastian Rauer, Veit Rothhammer, Florian Then Bergh, Mathias Wahl, Brigitte Wildemann, Ksenija Schirduan
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2025-10-01
Серія:	Frontiers in Neurology
Предмети:	multiple sclerosis SARS-CoV-2 vaccination immune response disease-modifying therapy
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1674742/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany

Схожі ресурси